Sign inGet started

VVUS

VIVUS INCCIK 881524 ☆ Sign in to watchCongress trades
Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
40

AI insights for VVUS PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
AI insights for VVUS
Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.
Upgrade to Pro · $99/yearAlready Pro? Log in

Daily buy vs sell · 90 days

No data yet.

Insiders

InsiderRoleTradesBoughtSoldLast trade
Ferrell Karen E.Director1$0$02020-02-20
Plutzky Jorge MDDirector39$0$02020-02-20
Norton David YDirector38$0$02020-02-20
KING THOMAS BRAXTONInterim Chief Executive Office5$0$02020-02-20
ROSENMAN HERMDirector45$159.0K$02020-02-20
KANGAS EDWARD ADirector1$0$02020-02-20
Amos John P.Chief Executive Officer14$1.14M$1.2K2020-01-29
Varghese Santosh TVP, Medical & Reg Affairs26$0$71.7K2020-01-29
Oki Mark KSVP, CFO, CAO11$40.7K$02020-01-29
Slebir John LVP, General Counsel30$0$357.6K2020-01-29
Roberts Eric WDirector102$41.0K$02019-02-28
Suh KennethPresident1$0$02019-01-23
Oehrlein M. ScottChief Operations Officer4$0$02019-01-23
Shaw AllanDirector103$0$02018-10-26
Fischer Seth H.Z.Other11$18.7K$02018-01-01
North Tide Capital Master, LP10% Owner44$4.76M$1.79M2017-03-10
Laughlin ConanDirector, 10% Owner14$603.5K$589.6K2017-03-07
NORTH TIDE CAPITAL, LLC10% Owner16$492.8K$1.12M2017-03-02
Sris MayuOther35$0$02017-01-16
DENNER ALEXANDER JDirector5$4.87M$02015-10-30
Sanford Svai SInterim CFO7$0$1.3K2015-08-03
Day WesleyVP, Clinical Research26$0$2.54M2015-07-01
MARSH GUY PVP, US Operations & GM43$0$4.11M2015-01-29
Colin Samuel FDirector, 10% Owner2$0$02014-05-01
MORRIS TIMOTHY EVP, Finance and CFO40$0$7.89M2013-09-05
ASTRUE MICHAEL JDirector2$119.6K$02013-09-04
JOHANNES JACOB PIETER KASTELEINDirector1$0$02013-08-14
CARROLL J MARTINDirector2$0$02013-08-14
LOGAN MARK BDirector28$0$1.83M2013-08-14
WILSON ROBERT NDirector2$0$02013-08-14
Zook Anthony P.Chief Executive Officer1$0$02013-07-25
BIRO JON C10% Owner1$25.7K$02013-06-27
MARIO ERNESTDirector6$758.9K$02013-05-29
Perry LeeVP & Chief Accounting Officer56$0$5.86M2013-01-25
SHORTLIFFE LINDA M DAIRIKIDirector45$0$2.50M2013-01-25
TAM PETER YPresident61$0$9.81M2013-01-25
MILLER MICHAEL PATRICKChief Commercial Officer13$0$2.09M2013-01-25
CASAMENTO CHARLES JDirector23$0$910.2K2013-01-25
WILSON LELAND FChief Executive Officer37$0$10.05M2013-01-25
MILLER MICHAEL /NY/Chief Commercial Officer2$0$02012-01-27

Trade history

InsiderRoleCodeTradeFiledSharesPriceValueOwned after
Ferrell Karen E.Director A Award deriv2020-02-202020-02-2415,000— $015,000SEC↗
KANGAS EDWARD ADirector A Award deriv2020-02-202020-02-2415,000— $015,000SEC↗
KING THOMAS BRAXTONDirector A Award deriv2020-02-202020-02-2415,000— $015,000SEC↗
Norton David YDirector A Award deriv2020-02-202020-02-2415,000— $015,000SEC↗
Plutzky Jorge MDDirector A Award deriv2020-02-202020-02-2415,000— $015,000SEC↗
ROSENMAN HERMDirector A Award deriv2020-02-202020-02-2415,000— $015,000SEC↗
Varghese Santosh TChief Medical Officer A Award deriv2020-01-292020-01-3132,000— $032,000SEC↗
Slebir John LSVP, Business Development & A Award deriv2020-01-292020-01-3132,000— $032,000SEC↗
Oki Mark KChief Financial Officer & CA A Award deriv2020-01-292020-01-3132,000— $032,000SEC↗
Amos John P.Chief Executive Officer A Award deriv2020-01-292020-01-31137,500— $0137,500SEC↗
Varghese Santosh TChief Medical Officer A Award2019-11-142019-11-18700$2.38 $1.7K9,242SEC↗
Oki Mark KSVP, CFO, CAO A Award2019-11-142019-11-18700$2.38 $1.7K12,100SEC↗
Varghese Santosh TChief Medical Officer A Award2019-05-142019-05-15700$2.84 $2.0K8,542SEC↗
Oki Mark KSVP, CFO, CAO A Award2019-05-142019-05-15700$2.84 $2.0K11,400SEC↗
Amos John P.Chief Executive Officer P Buy2019-03-012019-04-1011,000$4.85 $53.3K181,850SEC↗
Amos John P.Chief Executive Officer P Buy2019-03-012019-03-0411,000$4.85 $53.3K1,719,500SEC↗
Roberts Eric WDirector P Buy2019-02-282019-03-048,500$4.82 $41.0K16,660SEC↗
Amos John P.Chief Executive Officer A Award deriv2019-01-232019-01-25137,500— $0137,500SEC↗
Suh KennethPresident A Award deriv2019-01-232019-01-2585,000— $085,000SEC↗
Slebir John LSVP, Business Development & A Award deriv2019-01-232019-01-2532,000— $032,000SEC↗
Oehrlein M. ScottChief Operations Officer A Award deriv2019-01-232019-01-2531,000— $031,000SEC↗
Oki Mark KChief Financial Officer & CA A Award deriv2019-01-232019-01-2532,000— $032,000SEC↗
Varghese Santosh TChief Medical Officer A Award deriv2019-01-232019-01-2532,000— $032,000SEC↗
Oki Mark KChief Financial Officer & CA A Award2018-11-142018-11-16700$2.71 $1.9K10,700SEC↗
Varghese Santosh TChief Medical Officer A Award2018-11-142018-11-16700$2.71 $1.9K7,842SEC↗
Oki Mark KChief Financial Officer & CA P Buy2018-11-062018-11-0710,000$4.07 $40.7K10,000SEC↗
Norton David YDirector A Award deriv2018-10-262018-10-2915,000— $015,000SEC↗
KING THOMAS BRAXTONDirector A Award deriv2018-10-262018-10-2915,000— $015,000SEC↗
Plutzky Jorge MDDirector A Award deriv2018-10-262018-10-2915,000— $015,000SEC↗
ROSENMAN HERMDirector A Award deriv2018-10-262018-10-2915,000— $015,000SEC↗
Shaw AllanDirector A Award deriv2018-10-262018-10-2915,000— $015,000SEC↗
Roberts Eric WDirector A Award deriv2018-10-262018-10-2915,000— $015,000SEC↗
Roberts Eric WDirector M Exercise2018-10-012018-10-03139— $08,203SEC↗
Roberts Eric WDirector F Tax w/h2018-10-012018-10-0343$5.63 $2428,160SEC↗
Shaw AllanDirector F Tax w/h2018-10-012018-10-0343$5.63 $2426,389SEC↗
Shaw AllanDirector M Exercise2018-10-012018-10-03139— $06,432SEC↗
Shaw AllanDirector M Exercise deriv2018-09-152018-09-18139— $0139SEC↗
Roberts Eric WDirector M Exercise deriv2018-09-152018-09-18139— $0139SEC↗
Roberts Eric WDirector M Exercise deriv2018-08-152018-08-161,389— $02,778SEC↗
Shaw AllanDirector M Exercise deriv2018-08-152018-08-161,389— $02,778SEC↗
Roberts Eric WDirector F Tax w/h2018-08-152018-08-16438$0.63 $27680,632SEC↗
Roberts Eric WDirector M Exercise2018-08-152018-08-161,389— $081,070SEC↗
Shaw AllanDirector M Exercise2018-08-152018-08-161,389— $063,366SEC↗
Shaw AllanDirector F Tax w/h2018-08-152018-08-16438$0.63 $27662,928SEC↗
Shaw AllanDirector M Exercise deriv2018-07-152018-07-171,389— $04,167SEC↗
Roberts Eric WDirector M Exercise deriv2018-07-152018-07-171,389— $04,167SEC↗
Shaw AllanDirector F Tax w/h2018-07-152018-07-17439$0.77 $33861,977SEC↗
Shaw AllanDirector M Exercise2018-07-152018-07-171,389— $062,416SEC↗
Roberts Eric WDirector M Exercise2018-07-152018-07-171,389— $080,120SEC↗
Roberts Eric WDirector F Tax w/h2018-07-152018-07-17439$0.77 $33879,681SEC↗
ROSENMAN HERMDirector M Exercise deriv2018-06-292018-07-0325,000— $050,000SEC↗
ROSENMAN HERMDirector M Exercise2018-06-292018-07-0325,000$0.70 $17.5K311,671SEC↗
KING THOMAS BRAXTONDirector A Award deriv2018-06-152018-06-19200,000— $0200,000SEC↗
Roberts Eric WDirector M Exercise deriv2018-06-152018-06-191,389— $05,556SEC↗
Shaw AllanDirector A Award deriv2018-06-152018-06-19100,000— $0100,000SEC↗
Shaw AllanDirector M Exercise deriv2018-06-152018-06-191,389— $05,556SEC↗
Roberts Eric WDirector F Tax w/h2018-06-152018-06-19438$0.84 $36878,731SEC↗
Roberts Eric WDirector M Exercise2018-06-152018-06-191,389— $079,169SEC↗
Shaw AllanDirector F Tax w/h2018-06-152018-06-19438$0.84 $36861,027SEC↗
Shaw AllanDirector M Exercise2018-06-152018-06-191,389— $061,465SEC↗
ROSENMAN HERMDirector P Buy2018-06-012018-06-0550,000$0.77 $38.5K50,000SEC↗
ROSENMAN HERMDirector P Buy2018-05-292018-05-3150,000$0.79 $39.5K286,671SEC↗
ROSENMAN HERMDirector M Exercise deriv2018-05-212018-05-2375,000— $075,000SEC↗
ROSENMAN HERMDirector M Exercise2018-05-212018-05-2375,000$0.70 $52.5K136,671SEC↗
ROSENMAN HERMDirector P Buy2018-05-212018-05-23100,000$0.81 $81.0K236,671SEC↗
Amos John P.Chief Executive Officer P Buy2018-05-182018-05-22270,000$0.77 $207.9K1,710,000SEC↗
Amos John P.Chief Executive Officer S Sale2018-05-182018-05-221,500$0.77 $1.2K1,708,500SEC↗
Amos John P.Chief Executive Officer P Buy2018-05-172018-05-21360,000$0.69 $248.4K1,440,000SEC↗
Amos John P.Chief Executive Officer P Buy2018-05-162018-05-17270,000$0.58 $156.6K1,080,000SEC↗
Roberts Eric WDirector M Exercise deriv2018-05-152018-05-171,389— $06,945SEC↗
Shaw AllanDirector M Exercise deriv2018-05-152018-05-171,389— $06,945SEC↗
Amos John P.Chief Executive Officer P Buy2018-05-152018-05-17270,000$0.54 $145.8K810,000SEC↗
Roberts Eric WDirector M Exercise2018-05-152018-05-171,389— $078,277SEC↗
Roberts Eric WDirector D To issuer2018-05-152018-05-17497$0.52 $25877,780SEC↗
Shaw AllanDirector D To issuer2018-05-152018-05-17438$0.52 $22860,076SEC↗
Shaw AllanDirector M Exercise2018-05-152018-05-171,389— $060,514SEC↗
Amos John P.Chief Executive Officer P Buy2018-05-142018-05-15270,000$0.51 $137.7K540,000SEC↗
Amos John P.Chief Executive Officer P Buy2018-05-112018-05-15270,000$0.52 $140.4K270,000SEC↗
Amos John P.Chief Executive Officer A Award deriv2018-04-302018-08-09995,000$0.37 $368.1K995,000SEC↗
Oehrlein M. ScottChief Operations Officer A Award deriv2018-04-302018-08-09239,000$0.37 $88.4K239,000SEC↗
Amos John P.Chief Executive Officer A Award deriv2018-04-302018-05-022,700,000— $02,700,000SEC↗
Amos John P.Chief Executive Officer A Award deriv2018-04-302018-05-02200,000— $0200,000SEC↗
Slebir John LSVP, Business Development & A Award deriv2018-04-302018-05-02200,000— $0200,000SEC↗
Oki Mark KChief Financial Officer & CA A Award deriv2018-04-302018-05-02200,000— $0200,000SEC↗
Oehrlein M. ScottChief Operations Officer A Award deriv2018-04-302018-05-02620,000— $0620,000SEC↗
Oehrlein M. ScottChief Operations Officer A Award deriv2018-04-302018-05-02200,000— $0200,000SEC↗
Roberts Eric WDirector M Exercise deriv2018-04-152018-04-171,389— $08,334SEC↗
Shaw AllanDirector M Exercise deriv2018-04-152018-04-171,389— $08,334SEC↗
Roberts Eric WDirector D To issuer2018-04-152018-04-17438$0.42 $18476,888SEC↗
Roberts Eric WDirector M Exercise2018-04-152018-04-171,389— $077,326SEC↗
Shaw AllanDirector D To issuer2018-04-152018-04-17438$0.42 $18459,125SEC↗
Shaw AllanDirector M Exercise2018-04-152018-04-171,389— $059,563SEC↗
Varghese Santosh TChief Medical Officer S Sale2018-04-032018-04-04390$0.34 $13371,415SEC↗
Slebir John LSVP, Business Development & D To issuer2018-04-012018-04-03559$0.36 $201134,010SEC↗
Roberts Eric WDirector M Exercise deriv2018-03-152018-03-191,389— $09,723SEC↗
Shaw AllanDirector M Exercise deriv2018-03-152018-03-191,389— $09,723SEC↗
Roberts Eric WDirector D To issuer2018-03-152018-03-19438$0.48 $21075,937SEC↗
Roberts Eric WDirector M Exercise2018-03-152018-03-191,389— $076,375SEC↗
Shaw AllanDirector M Exercise2018-03-152018-03-191,389— $058,612SEC↗
Shaw AllanDirector D To issuer2018-03-152018-03-19438$0.48 $21058,174SEC↗
Shaw AllanDirector A Award deriv2018-03-092018-03-13300,000— $0300,000SEC↗
Roberts Eric WDirector M Exercise deriv2018-02-152018-02-201,389— $011,112SEC↗
Shaw AllanDirector M Exercise deriv2018-02-152018-02-201,389— $011,112SEC↗
Roberts Eric WDirector D To issuer2018-02-152018-02-20497$0.46 $22974,986SEC↗
Roberts Eric WDirector M Exercise2018-02-152018-02-201,389— $075,483SEC↗
Shaw AllanDirector M Exercise2018-02-152018-02-201,389— $057,661SEC↗
Shaw AllanDirector D To issuer2018-02-152018-02-20438$0.46 $20157,223SEC↗
Oki Mark KChief Financial Officer & CA A Award deriv2018-02-022018-02-06350,000— $0350,000SEC↗
Slebir John LSVP, Business Development & A Award deriv2018-02-022018-02-06425,000— $0425,000SEC↗
Varghese Santosh TChief Medical Officer A Award deriv2018-02-022018-02-06262,500— $0262,500SEC↗
Varghese Santosh TChief Medical Officer S Sale2018-01-312018-02-01491$0.43 $21171,805SEC↗
Slebir John LSVP, Business Development & D To issuer2018-01-282018-01-30614$0.46 $282134,569SEC↗
KING THOMAS BRAXTONInterim Chief Executive Offi A Award deriv2018-01-262018-01-30600,000— $0600,000SEC↗
Roberts Eric WDirector M Exercise deriv2018-01-152018-01-171,389— $012,501SEC↗
Shaw AllanDirector M Exercise deriv2018-01-152018-01-171,389— $012,501SEC↗
Roberts Eric WDirector D To issuer2018-01-152018-01-17539$0.51 $27574,094SEC↗
Roberts Eric WDirector M Exercise2018-01-152018-01-171,389— $074,633SEC↗
Shaw AllanDirector M Exercise2018-01-152018-01-171,389— $056,752SEC↗
Shaw AllanDirector D To issuer2018-01-152018-01-17480$0.51 $24556,272SEC↗
Slebir John LSVP, Business Development & D To issuer2018-01-012018-01-03710$0.50 $355135,183SEC↗
Varghese Santosh TChief Medical Officer S Sale2018-01-012018-01-03444$0.51 $22672,296SEC↗
Fischer Seth H. Z.Other D To issuer2018-01-012018-01-032,102$0.50 $1.1K633,978SEC↗
Roberts Eric WDirector M Exercise deriv2017-12-152017-12-191,389— $013,890SEC↗
Shaw AllanDirector M Exercise deriv2017-12-152017-12-191,389— $013,890SEC↗
Roberts Eric WDirector D To issuer2017-12-152017-12-19540$0.53 $28673,244SEC↗
Roberts Eric WDirector M Exercise2017-12-152017-12-191,389— $073,784SEC↗
Shaw AllanDirector M Exercise2017-12-152017-12-191,389— $055,844SEC↗
Shaw AllanDirector D To issuer2017-12-152017-12-19481$0.53 $25555,363SEC↗
Roberts Eric WDirector M Exercise deriv2017-11-152017-11-171,389— $015,279SEC↗
Shaw AllanDirector M Exercise deriv2017-11-152017-11-171,389— $015,279SEC↗
Roberts Eric WDirector D To issuer2017-11-152017-11-17540$0.66 $35672,395SEC↗
Roberts Eric WDirector M Exercise2017-11-152017-11-171,389— $072,935SEC↗
Shaw AllanDirector M Exercise2017-11-152017-11-171,389— $054,936SEC↗
Shaw AllanDirector D To issuer2017-11-152017-11-17481$0.66 $31754,455SEC↗
Norton David YDirector A Award deriv2017-10-272017-10-31150,000— $0150,000SEC↗
Norton David YDirector M Exercise deriv2017-10-272017-10-3112,500— $00SEC↗
Plutzky Jorge MDDirector A Award deriv2017-10-272017-10-31150,000— $0150,000SEC↗
Plutzky Jorge MDDirector M Exercise deriv2017-10-272017-10-3112,500— $00SEC↗
Roberts Eric WDirector M Exercise deriv2017-10-272017-10-3112,500— $00SEC↗
Roberts Eric WDirector A Award deriv2017-10-272017-10-31150,000— $0150,000SEC↗
ROSENMAN HERMDirector A Award deriv2017-10-272017-10-31150,000— $0150,000SEC↗
ROSENMAN HERMDirector M Exercise deriv2017-10-272017-10-3112,500— $00SEC↗
Shaw AllanDirector A Award deriv2017-10-272017-10-31150,000— $0150,000SEC↗
Shaw AllanDirector M Exercise deriv2017-10-272017-10-3112,500— $00SEC↗
Norton David YDirector D To issuer2017-10-272017-10-313,125$0.70 $2.2K67,120SEC↗
Norton David YDirector M Exercise2017-10-272017-10-3112,500— $070,245SEC↗
Plutzky Jorge MDDirector M Exercise2017-10-272017-10-3112,500— $084,921SEC↗
Plutzky Jorge MDDirector D To issuer2017-10-272017-10-313,762$0.70 $2.6K81,159SEC↗
Roberts Eric WDirector D To issuer2017-10-272017-10-314,859$0.70 $3.4K71,546SEC↗
Roberts Eric WDirector M Exercise2017-10-272017-10-3112,500— $076,405SEC↗
ROSENMAN HERMDirector M Exercise2017-10-272017-10-3112,500— $066,074SEC↗
ROSENMAN HERMDirector D To issuer2017-10-272017-10-314,403$0.70 $3.1K61,671SEC↗
Shaw AllanDirector M Exercise2017-10-272017-10-3112,500— $057,874SEC↗
Shaw AllanDirector D To issuer2017-10-272017-10-314,327$0.70 $3.0K53,547SEC↗
Shaw AllanDirector D To issuer2017-10-162017-10-17480$0.86 $41345,374SEC↗
Roberts Eric WDirector D To issuer2017-10-162017-10-17540$0.86 $46463,905SEC↗
Shaw AllanDirector M Exercise deriv2017-10-152017-10-171,389— $016,668SEC↗
Roberts Eric WDirector M Exercise deriv2017-10-152017-10-171,389— $016,668SEC↗
Shaw AllanDirector M Exercise2017-10-152017-10-171,389— $045,854SEC↗
Roberts Eric WDirector M Exercise2017-10-152017-10-171,389— $064,445SEC↗
Varghese Santosh TChief Medical Officer S Sale2017-10-032017-10-04434$0.97 $42172,740SEC↗
Roberts Eric WDirector M Exercise deriv2017-09-152017-09-191,389— $018,057SEC↗
Shaw AllanDirector M Exercise deriv2017-09-152017-09-191,389— $018,057SEC↗
Roberts Eric WDirector M Exercise2017-09-152017-09-191,389— $063,596SEC↗
Roberts Eric WDirector D To issuer2017-09-152017-09-19540$1.00 $54063,056SEC↗
Shaw AllanDirector D To issuer2017-09-152017-09-19481$1.00 $48144,465SEC↗
Shaw AllanDirector M Exercise2017-09-152017-09-191,389— $044,946SEC↗
Roberts Eric WDirector M Exercise deriv2017-08-152017-08-171,388— $019,446SEC↗
Shaw AllanDirector M Exercise deriv2017-08-152017-08-171,388— $019,446SEC↗
Roberts Eric WDirector M Exercise2017-08-152017-08-171,388— $062,746SEC↗
Roberts Eric WDirector D To issuer2017-08-152017-08-17539$1.01 $54462,207SEC↗
Shaw AllanDirector D To issuer2017-08-152017-08-17480$1.01 $48543,557SEC↗
Shaw AllanDirector M Exercise2017-08-152017-08-171,388— $044,037SEC↗
Norton David YDirector M Exercise deriv2017-08-082017-08-1012,500— $012,500SEC↗
Plutzky Jorge MDDirector M Exercise deriv2017-08-082017-08-1012,500— $012,500SEC↗
Roberts Eric WDirector M Exercise deriv2017-08-082017-08-1012,500— $012,500SEC↗
ROSENMAN HERMDirector M Exercise deriv2017-08-082017-08-1012,500— $012,500SEC↗
Shaw AllanDirector M Exercise deriv2017-08-082017-08-1012,500— $012,500SEC↗
Norton David YDirector D To issuer2017-08-082017-08-103,125$1.01 $3.2K57,745SEC↗
Norton David YDirector M Exercise2017-08-082017-08-1012,500— $060,870SEC↗
Plutzky Jorge MDDirector M Exercise2017-08-082017-08-1012,500— $076,183SEC↗
Plutzky Jorge MDDirector D To issuer2017-08-082017-08-103,762$1.01 $3.8K72,421SEC↗
Roberts Eric WDirector D To issuer2017-08-082017-08-104,859$1.01 $4.9K61,358SEC↗
Roberts Eric WDirector M Exercise2017-08-082017-08-1012,500— $066,217SEC↗
ROSENMAN HERMDirector M Exercise2017-08-082017-08-1012,500— $057,977SEC↗
ROSENMAN HERMDirector D To issuer2017-08-082017-08-104,403$1.01 $4.4K53,574SEC↗
Shaw AllanDirector M Exercise2017-08-082017-08-1012,500— $046,976SEC↗
Shaw AllanDirector D To issuer2017-08-082017-08-104,327$1.01 $4.4K42,649SEC↗
KING THOMAS BRAXTONDirector A Award deriv2017-07-272017-07-31125,000— $0125,000SEC↗
Shaw AllanDirector M Exercise deriv2017-07-152017-07-181,389— $020,834SEC↗
Roberts Eric WDirector M Exercise deriv2017-07-152017-07-181,389— $020,834SEC↗
Shaw AllanDirector M Exercise2017-07-152017-07-181,389— $034,957SEC↗
Shaw AllanDirector D To issuer2017-07-152017-07-18481$1.27 $61134,476SEC↗
Roberts Eric WDirector M Exercise2017-07-152017-07-181,389— $054,257SEC↗
Roberts Eric WDirector D To issuer2017-07-152017-07-18540$1.27 $68653,717SEC↗
Varghese Santosh TChief Medical Officer S Sale2017-07-032017-07-05423$1.23 $52073,174SEC↗
Roberts Eric WDirector M Exercise deriv2017-06-152017-06-191,389— $022,223SEC↗
Shaw AllanDirector M Exercise deriv2017-06-152017-06-191,389— $022,223SEC↗
Norton David YDirector D To issuer2017-06-152017-06-193,125$1.17 $3.7K48,370SEC↗
Plutzky Jorge MDDirector D To issuer2017-06-152017-06-193,762$1.17 $4.4K63,683SEC↗
Roberts Eric WDirector M Exercise2017-06-152017-06-191,389— $053,407SEC↗
Roberts Eric WDirector D To issuer2017-06-152017-06-19539$1.17 $63152,868SEC↗
Roberts Eric WDirector D To issuer2017-06-152017-06-194,859$1.17 $5.7K52,018SEC↗
ROSENMAN HERMDirector D To issuer2017-06-152017-06-194,403$1.17 $5.2K45,477SEC↗
Shaw AllanDirector D To issuer2017-06-152017-06-194,327$1.17 $5.1K32,659SEC↗
Shaw AllanDirector M Exercise2017-06-152017-06-191,389— $034,048SEC↗
Shaw AllanDirector D To issuer2017-06-152017-06-19480$1.17 $56233,568SEC↗
Norton David YDirector M Exercise deriv2017-05-082017-06-1912,500— $025,000SEC↗
Plutzky Jorge MDDirector M Exercise deriv2017-05-082017-06-1912,500— $025,000SEC↗
Roberts Eric WDirector M Exercise deriv2017-05-082017-06-1912,500— $025,000SEC↗
ROSENMAN HERMDirector M Exercise deriv2017-05-082017-06-1912,500— $025,000SEC↗
Shaw AllanDirector M Exercise deriv2017-05-082017-06-1912,500— $025,000SEC↗
Norton David YDirector M Exercise2017-05-082017-06-1912,500— $051,495SEC↗
Plutzky Jorge MDDirector M Exercise2017-05-082017-06-1912,500— $067,445SEC↗
Roberts Eric WDirector M Exercise2017-05-082017-06-1912,500— $056,877SEC↗
ROSENMAN HERMDirector M Exercise2017-05-082017-06-1912,500— $049,880SEC↗
Shaw AllanDirector M Exercise2017-05-082017-06-1912,500— $036,986SEC↗
Roberts Eric WDirector M Exercise deriv2017-04-152017-04-181,389— $023,612SEC↗
Shaw AllanDirector M Exercise deriv2017-04-152017-04-181,389— $023,612SEC↗
Roberts Eric WDirector D To issuer2017-04-152017-04-18540$1.03 $55644,377SEC↗
Roberts Eric WDirector M Exercise2017-04-152017-04-181,389— $044,917SEC↗
Shaw AllanDirector M Exercise2017-04-152017-04-181,389— $024,967SEC↗
Shaw AllanDirector D To issuer2017-04-152017-04-18481$1.03 $49524,486SEC↗
Varghese Santosh TChief Medical Officer S Sale2017-04-042017-04-06440$1.08 $47573,597SEC↗
Shaw AllanDirector M Exercise deriv2017-03-152017-03-171,389— $025,001SEC↗
Roberts Eric WDirector M Exercise deriv2017-03-152017-03-171,389— $025,001SEC↗
Shaw AllanDirector D To issuer2017-03-152017-03-17480$1.11 $53323,578SEC↗
Shaw AllanDirector M Exercise2017-03-152017-03-171,389— $024,058SEC↗
Roberts Eric WDirector D To issuer2017-03-152017-03-17539$1.11 $59843,528SEC↗
Roberts Eric WDirector M Exercise2017-03-152017-03-171,389— $044,067SEC↗
North Tide Capital Master, LP10% Owner S Sale2017-03-102017-03-1077,000$1.17 $90.1K10,466,700SEC↗
North Tide Capital Master, LP10% Owner S Sale2017-03-092017-03-10237,100$1.20 $284.5K10,543,700SEC↗
North Tide Capital Master, LP10% Owner S Sale2017-03-092017-03-10435,300$1.21 $526.7K10,780,800SEC↗
North Tide Capital Master, LP10% Owner S Sale2017-03-092017-03-1050,000$1.25 $62.5K11,216,100SEC↗
North Tide Capital Master, LP10% Owner S Sale2017-03-082017-03-10350,000$1.05 $367.5K11,266,100SEC↗
Laughlin ConanDirector, 10% Owner S Sale2017-03-072017-03-07105,100$1.07 $112.5K11,656,100SEC↗
Laughlin ConanDirector, 10% Owner S Sale2017-03-072017-03-0740,000$1.08 $43.2K11,616,100SEC↗
Laughlin ConanDirector, 10% Owner S Sale2017-03-062017-03-0710,000$1.10 $11.0K11,766,000SEC↗
Laughlin ConanDirector, 10% Owner S Sale2017-03-062017-03-074,800$1.10 $5.3K11,761,200SEC↗
Laughlin ConanDirector, 10% Owner S Sale2017-03-032017-03-0731,200$1.11 $34.6K11,776,000SEC↗
Laughlin ConanDirector, 10% Owner S Sale2017-03-032017-03-071,700$1.11 $1.9K11,807,200SEC↗
NORTH TIDE CAPITAL, LLC10% Owner S Sale2017-03-022017-03-0220,000$1.13 $22.6K11,808,900SEC↗
NORTH TIDE CAPITAL, LLC10% Owner S Sale2017-03-012017-03-0242,000$1.13 $47.5K11,828,900SEC↗
NORTH TIDE CAPITAL, LLC10% Owner S Sale2017-03-012017-03-0272,600$1.14 $82.8K11,870,900SEC↗
NORTH TIDE CAPITAL, LLC10% Owner S Sale2017-02-282017-03-0225,500$1.12 $28.6K11,943,500SEC↗
Laughlin ConanDirector, 10% Owner S Sale2017-02-272017-02-2743,000$1.13 $48.6K11,969,000SEC↗
Laughlin ConanDirector, 10% Owner S Sale2017-02-272017-02-27107,000$1.13 $120.9K12,012,000SEC↗
Laughlin ConanDirector, 10% Owner S Sale2017-02-242017-02-2733,000$1.14 $37.6K12,119,000SEC↗
Laughlin ConanDirector, 10% Owner S Sale2017-02-232017-02-27150,000$1.16 $174.0K12,152,000SEC↗
North Tide Capital Master, LP10% Owner S Sale2017-02-222017-02-22109,336$1.11 $121.4K12,302,000SEC↗
North Tide Capital Master, LP10% Owner S Sale2017-02-212017-02-2252,164$1.10 $57.4K12,411,336SEC↗
North Tide Capital Master, LP10% Owner S Sale2017-02-172017-02-22300$1.11 $33312,463,500SEC↗
NORTH TIDE CAPITAL, LLC10% Owner S Sale2017-02-162017-02-1620,000$1.11 $22.2K12,593,800SEC↗
NORTH TIDE CAPITAL, LLC10% Owner S Sale2017-02-162017-02-16130,000$1.10 $143.0K12,463,800SEC↗
Roberts Eric WDirector M Exercise deriv2017-02-152017-02-171,389— $026,390SEC↗
Shaw AllanDirector M Exercise deriv2017-02-152017-02-171,389— $026,390SEC↗
NORTH TIDE CAPITAL, LLC10% Owner S Sale2017-02-152017-02-1640,090$1.11 $44.5K12,613,800SEC↗
Roberts Eric WDirector D To issuer2017-02-152017-02-17539$1.10 $59342,678SEC↗
Roberts Eric WDirector M Exercise2017-02-152017-02-171,389— $043,217SEC↗
Shaw AllanDirector M Exercise2017-02-152017-02-171,389— $023,149SEC↗
Shaw AllanDirector D To issuer2017-02-152017-02-17480$1.10 $52822,669SEC↗
NORTH TIDE CAPITAL, LLC10% Owner S Sale2017-02-142017-02-16115,000$1.10 $126.5K12,653,890SEC↗
North Tide Capital Master, LP10% Owner S Sale2017-02-132017-02-1367,000$1.10 $73.7K12,768,890SEC↗
North Tide Capital Master, LP10% Owner S Sale2017-02-102017-02-1346,008$1.11 $51.1K12,835,890SEC↗
North Tide Capital Master, LP10% Owner S Sale2017-02-092017-02-1363,402$1.11 $70.4K12,881,898SEC↗
Norton David YDirector M Exercise deriv2017-02-082017-02-1012,500— $037,500SEC↗
Shaw AllanDirector M Exercise deriv2017-02-082017-02-1012,500— $037,500SEC↗
ROSENMAN HERMDirector M Exercise deriv2017-02-082017-02-1012,500— $037,500SEC↗
Roberts Eric WDirector M Exercise deriv2017-02-082017-02-1012,500— $037,500SEC↗
Plutzky Jorge MDDirector M Exercise deriv2017-02-082017-02-1012,500— $037,500SEC↗
NORTH TIDE CAPITAL, LLC10% Owner S Sale2017-02-082017-02-0821,251$1.09 $23.2K12,945,300SEC↗
NORTH TIDE CAPITAL, LLC10% Owner S Sale2017-02-082017-02-08508,049$1.06 $538.5K12,966,551SEC↗
Norton David YDirector D To issuer2017-02-082017-02-103,125$1.08 $3.4K38,995SEC↗
Norton David YDirector M Exercise2017-02-082017-02-1012,500— $042,120SEC↗
Shaw AllanDirector D To issuer2017-02-082017-02-104,327$1.08 $4.7K21,760SEC↗
Shaw AllanDirector M Exercise2017-02-082017-02-1012,500— $026,087SEC↗
ROSENMAN HERMDirector D To issuer2017-02-082017-02-104,403$1.08 $4.8K37,380SEC↗
ROSENMAN HERMDirector M Exercise2017-02-082017-02-1012,500— $041,783SEC↗
Roberts Eric WDirector M Exercise2017-02-082017-02-1012,500— $046,687SEC↗
Roberts Eric WDirector D To issuer2017-02-082017-02-104,859$1.08 $5.2K41,828SEC↗
Plutzky Jorge MDDirector M Exercise2017-02-082017-02-1012,500— $058,707SEC↗
Plutzky Jorge MDDirector D To issuer2017-02-082017-02-103,762$1.08 $4.1K54,945SEC↗
NORTH TIDE CAPITAL, LLC10% Owner S Sale2017-02-072017-02-086,200$1.11 $6.9K13,474,600SEC↗
NORTH TIDE CAPITAL, LLC10% Owner S Sale2017-02-062017-02-0828,027$1.10 $30.8K13,480,800SEC↗
North Tide Capital Master, LP10% Owner S Sale2017-02-032017-02-0353,433$1.12 $59.8K13,508,827SEC↗
North Tide Capital Master, LP10% Owner S Sale2017-02-022017-02-033,200$1.13 $3.6K13,562,260SEC↗
North Tide Capital Master, LP10% Owner S Sale2017-02-012017-02-0321,000$1.13 $23.7K13,565,460SEC↗
North Tide Capital Master, LP10% Owner S Sale2017-02-012017-02-031,000$1.14 $1.1K13,586,460SEC↗
Varghese Santosh TChief Medical Officer S Sale2017-01-282017-01-31429$1.11 $47674,037SEC↗
Varghese Santosh TChief Medical Officer A Award deriv2017-01-272017-01-31385,000— $0385,000SEC↗
Slebir John LSVP, Business Development & A Award deriv2017-01-272017-01-31437,500— $0437,500SEC↗
Oki Mark KChief Financial Officer & CA A Award deriv2017-01-272017-01-31385,000— $0385,000SEC↗
Fischer Seth H. Z.Chief Executive Officer A Award deriv2017-01-272017-01-311,000,000— $01,000,000SEC↗
Fischer Seth H. Z.Chief Executive Officer A Award2017-01-272017-01-31150,000— $0636,080SEC↗
Sris MayuOther D To issuer deriv2017-01-162017-01-1827,779— $00SEC↗
Sris MayuOther M Exercise deriv2017-01-162017-01-188,333— $041,667SEC↗
Sris MayuOther D To issuer deriv2017-01-162017-01-1841,667— $00SEC↗
Sris MayuOther M Exercise2017-01-162017-01-188,333— $025,001SEC↗
Sris MayuOther D To issuer2017-01-162017-01-182,083$1.20 $2.5K22,918SEC↗
Sris MayuOther M Exercise deriv2017-01-152017-01-181,389— $027,779SEC↗